Filing Flows › 60 Degrees Pharmaceuticals (SXTP) › Q2 2026 › vs Q2 2025
60 Degrees Pharmaceuticals (SXTP) Q2 2026 vs Q2 2025 (year over year)
60 Degrees Pharmaceuticals's revenue rose $107K (+106%) from $101K in Q2 2025 to $208K in Q2 2026.
60 Degrees Pharmaceuticals, Q2 2026: revenue $208K (+106% year over year), net loss $2.3M, operating cash flow −$2.2M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $208K | $101K | $107K | +106% |
| Other income, net | $6K | −$129K | $134K | — |
| Net loss | $2.3M | $1.7M | $531K | +31% |
| Costs & expenses | $2.5M | $1.8M | $643K | +35% |
| Operating costs | $2.5M | $1.7M | $772K | +45% |
| Cost of revenue | $151K | $50K | $101K | +202% |
| Operating cash sources | $2.4M | $1.5M | $813K | +52% |
| Depreciation & amortization | $31K | $20K | $11K | +57% |
| Share-based compensation | $98K | $79K | $20K | +25% |
| Cash used in operations | $2.2M | $1.5M | $782K | +54% |
| Net loss absorbed | $2.3M | $1.7M | $531K | +31% |
| Working capital & other | $95K | −$187K | $282K | — |
Questions
How much did 60 Degrees Pharmaceuticals's revenue grow year over year in Q2 2026?
60 Degrees Pharmaceuticals's revenue rose $107K (+106%) from $101K in Q2 2025 to $208K in Q2 2026.